FDA Tobacco Product Director Brian King to Speak on E-Cigarettes

Jan.20.2023
FDA Tobacco Product Director Brian King to Speak on E-Cigarettes
FDA's Brian King to participate in public dialogue about e-cigarettes and harm reduction. Open to industry stakeholders on Feb. 24th.

Brian King, Director of the FDA's Center for Tobacco Products, is set to participate in a public dialogue next month regarding e-cigarettes and harm reduction. King took on the role of Director in July 2022 and began implementing strong regulations on e-cigarettes, including strengthening the review process for PMTA, and issuing warning letters to non-compliant companies. Prior to this dialogue, King only made an appearance and delivered a speech at the Global Tobacco and Nicotine Forum in September of last year and has not interacted with the public since. This dialogue will be his first public interaction with industry professionals since taking on the role.


Brian King's speech at GTNF | Source: 2FIRSTS


The upcoming online event will be hosted by Gregory Conley, the Director of Legislation for the American Vaping Association (AVM), and newly appointed Vice President of AVM, Allison Boughner. The conference, titled "The Future of American Vaping: A Conversation with Dr. Brian King, Director of the FDA Center for Tobacco Products," will take place on February 24th at 1:00 pm EST and is open to the public, with registration available through this link.


According to 2FIRSTS, it is understood that the director King's speech at this conference may reveal the future direction of electronic cigarette regulation by the United States federal government.


The Washington News Center editor will provide extensive coverage of the event and bring updates as they become available. Stay tuned for more information.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.